Gregory P. Sargen — Executive Vice President of Corporate Development & Strategy at Cambrex Corporation

Mr. Gregory P. Sargen has been Executive Vice President of Corporate Development & Strategy at Cambrex Corporation since January 20, 2017. Mr. Sargen served as the Chief Financial Officer of Cambrex Corporation from February 9, 2007 to January 20, 2017 and its Executive Vice President from January 2011 to January 20, 2017 and also served as its Principal Accounting Officer until January 20, 2017. Mr. Sargen served as Vice President of Cambrex Corporation. since February 2007 and also served as its Vice President of Finance since February 2003. He has rare combination of broad financial experience, excellent business acumen and strong leadership skills. Mr. Sargen served as Vice President of Finance at Cambrex Corporation. since February 2003. Prior to Cambrex, he served as Vice President of Finance - Chemicals Manufacturing Division of Fisher Scientific International Inc. (n/k/a Thermo Fisher Scientific Inc.). He served as an Executive Vice President for Finance, Chief Financial Officer, Vice President and Corporate Controller of Exp@nets, Inc. from 1999 to 2002. From 1996 to 1998, he served as Vice President of Finance and Controller of Fischer Scientific International's Chemical Manufacturing Division. He worked at Ernst & Young LLP. Mr. Sargen held various positions in finance, accounting and audit with Merck & Company, Inc., Heat and Control, Inc., and Deloitte & Touche. He has been Director of Peregrine Pharmaceuticals, Inc. since November 27, 2017 and Avid Bioservices, Inc. since November 28, 2017. Mr. Sargen holds an MBA degree in Finance from the Wharton School of Business, the University of Pennsylvania and a B.S. in Accounting from Pennsylvania State University. Mr. Sargen is a Certified Public Accountant.